How stress hormone receptors alter the brain and behavior: Zebrafish study provides insights

Stress, the body's natural response to different types of challenges and daily problems, is an inherently harmless state ...

Johnson & Johnson: RYBREVANT (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...